Oculus Innovative shares soar after FDA approves scar treatment

(Reuters) - Oculus Innovative Sciences Inc's shares more than doubled after the U.S. Food and Drug Administration approved the company's anti-scar treatment for raised and red scars resulting from burns, surgical procedures and trauma wounds.

via Reuters: Health News Read More Here..